Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05612425 · ClinicalTrials.gov registry record · NA

Text Message Safety Behavior Fading for Appearance Concerns

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
203
Enrollment target

NCT05612425: Completed NA study, sponsored by Florida State University.

NCT05612425 is a NA study that has completed, run by Florida State University. The registered enrollment target is 203 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05612425, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
203 participants
Enrollment target

Study Summary

The current study aims to explore the efficacy of a text message based safety behavior fadinig intervention compared to an unhealthy behavior fading intervention for appearance concerns.

Primary Outcome

Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.

Interventions

  • BEHAVIORAL Safety Behavior Fading for Appearance Concerns
  • BEHAVIORAL Unhealthy Behavior Fading

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2024-01-12
Est. Completion 2024-04-15
Phase NA
Florida State University

219 total trials

What the finished NCT05612425 record still lists

NCT05612425 is an interventional study that assigns participants to a tested intervention. The registered 203 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 2 interventions - of which Safety Behavior Fading for Appearance Concerns is the first listed.

NCT05612425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05612425 about?

NCT05612425 is a clinical study titled "Text Message Safety Behavior Fading for Appearance Concerns". The current study aims to explore the efficacy of a text message based safety behavior fadinig intervention compared to an unhealthy behavior fading intervention for appearance concerns.

What is the current status of trial NCT05612425?

This trial is currently completed. It is a NA study. The enrollment target is 203 participants. The study started on 2024-01-12. Estimated completion is 2024-04-15.

What interventions are being tested in trial NCT05612425?

The interventions under investigation include: Safety Behavior Fading for Appearance Concerns (BEHAVIORAL), Unhealthy Behavior Fading (BEHAVIORAL).

Who is sponsoring clinical trial NCT05612425?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05612425's enrollment target sits among peer trials

203 504th of 2000 higher than 1,496 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05652686 · 203 participants · Phase 1

    A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

  • NCT06063122 · 203 participants · NA

    Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

  • NCT07031245 · 203 participants · NA

    Evidence-Based Quality Improvement to Reduce VA Primary Care Burnout

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05612425, the US trial registry maintained by the National Library of Medicine. NCT05612425 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.